Contraception Clinical Trial
Official title:
Postpartum Family Planning Utilization and Associated Factors Among Women During the First Year After Childbirth in Assiut District
Postpartum family planning is defined as prevention of unintended pregnancy and closely spaced pregnancies during the first 12 months after the child birth postpartum contraceptive utilization is important because some women resume ovulation after 28 days postpartum inter-pregnancy intervals shorter than 18 to 24 months have been associated with an increased risk of fetal and maternal deaths ,35% of children younger than five deaths could be avoided if births spaced 36 months
According to Egyptian demographic health survey , unmet need for family planning increased
from 11.6% in 2008 to be 12.6% in 2014, contraception prevalence rate decreased from 60% in
2008 to 59% in 2014.
In Assiut Contraception prevalence rate decreased form 47.4 in 2008 to 41.4 in 2014 Total
fertility rate increased from 3 in 2008 to 3.5 children/woman in 2014, Assiut Total fertility
rate was 4.2 children/woman in 2014 . projections for the year 2030 estimated that total
fertility rate would decline to be 2.1 births/woman if Contraceptive prevalence rate could
rise to be 74.4% .
Routine childhood immunization services include more than 500 million regular contacts
annually, most women seek child immunization for their children so each immunization
represents an opportunity to reach women with Postpartum family planning counselling so World
Health Organization recommends Postpartum family planning as a critical healthcare component
and World Contraception Day 26 September 2018, Met the theme"Postpartum family planning:
essential for ensuring woman health and their babies" World Health Organization for family
planning research agenda listed postpartum family planning utilization as a higher priority
score with score 83.90
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02577601 -
Impact of Combined Hormonal Contraceptives on UPA
|
Phase 4 | |
| Completed |
NCT03153644 -
Improving Contraceptive Care for Women With Medical Conditions
|
||
| Completed |
NCT04112095 -
Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use
|
Phase 3 | |
| Recruiting |
NCT05521646 -
Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative
|
N/A | |
| Active, not recruiting |
NCT04291001 -
Ovarian Function With ENG Implant and UPA Use
|
Early Phase 1 | |
| Completed |
NCT04568980 -
Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
|
||
| Completed |
NCT03438682 -
Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
|
||
| Active, not recruiting |
NCT01948882 -
Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women
|
N/A | |
| Enrolling by invitation |
NCT04997499 -
Adolescent Subcutaneous (SQ) Injection Video Validation
|
N/A | |
| Recruiting |
NCT03589040 -
Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant
|
Phase 2 | |
| Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
| Completed |
NCT03154125 -
Sayana® Press Extension Study
|
Phase 3 | |
| Withdrawn |
NCT03725358 -
A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon.
|
N/A | |
| Completed |
NCT02957630 -
"E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study"
|
Phase 1/Phase 2 | |
| Completed |
NCT02456584 -
Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods
|
Phase 1 | |
| Completed |
NCT02718222 -
Impact and Performance of Institutionalizing Immediate Post-partum IUD Services
|
N/A | |
| Recruiting |
NCT02121067 -
LNG-IUS at 2 Weeks Postpartum
|
Phase 4 | |
| Terminated |
NCT02169869 -
Immediate Postplacental IUD Insertion
|
N/A | |
| Recruiting |
NCT02292056 -
Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions
|
N/A | |
| Withdrawn |
NCT01930994 -
Kenya Sino-implant (II) PK Study
|
N/A |